The oncogenic capacity of LAMC2 has been well-documented in lung cancer, undifferentiated thyroid carcinoma, cholangiocarcinoma, laryngeal cancer, ovarian cancer and pancreatic cancer. The gene discussed is LAMC2; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.